Buy Tofisopam
Tofisopam

$1.78
Active Ingredient
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Tofisopam Properties

Active Ingredients
Primary Category
Therapeutic Class
Pharmacological Class
Benzodiazepine Derivative (non-sedating)
Minor Side Effects
Moderate Side Effects
Dosage Forms
Tablets
Administration Route
Oral
Mechanism of Action
Acts on specific receptors in the brain to reduce anxiety without causing significant sedation or muscle relaxation, making it different from typical benzodiazepines.
Prescription Status
Rx
Patient Summary
Tofisopam is a medication used to relieve anxiety and stress. Unlike some other anxiety medications, it aims to reduce feelings of unease without causing strong drowsiness, allowing individuals to maintain their daily activities.
Onset Time
Within 30-60 minutes
Duration
4-6 hours
Storage Instructions
Store at room temperature, away from moisture and light
Age Restrictions
Adults
Pregnancy Use
Consult doctor before use during pregnancy or breastfeeding

About Tofisopam

Generic Tofisopam is a benzodiazepine-derived anxiolytic that belongs to the 1,4-benzodiazepine class but differs markedly from classic agents such as diazepam. In Australia it is not listed on the Therapeutic Goods Administration (TGA) register, so it is generally obtained through specialised import channels rather than routine pharmacy supply. The medication is indicated for the relief of anxiety, tension, and stress-related symptoms, and it is sometimes explored in alcohol-withdrawal protocols. Its unique pharmacology provides anxiolysis without the pronounced sedation, muscle relaxation, or anticonvulsant effects typical of many benzodiazepines.

What is Generic Tofisopam?

Generic Tofisopam is marketed as a 50 mg oral tablet that exerts its therapeutic effect primarily through modulation of central nervous system pathways distinct from the GABA-A receptor complex. First introduced in Europe in the 1970s, it received marketing authorisation in several countries for short-term management of anxiety disorders. In Australia, the product is classified as an unapproved therapeutic good, meaning it can only be accessed via a TGA-approved personal import scheme or through an online pharmacy that complies with international regulations.

How Tofisopam Works

Tofisopam’s mechanism of action is not fully elucidated, but pre-clinical studies suggest it interacts with sigma-1 receptors and influences serotonergic transmission. By binding to sigma-1 sites, the drug may regulate calcium signalling and neuroplasticity, leading to a reduction in neuronal hyper-excitability that underlies anxiety. Unlike conventional benzodiazepines, Tofisopam does not potentiate the inhibitory effect of GABA at the GABA-A receptor, which explains its limited sedative and muscle-relaxant properties.

Pharmacokinetic data indicate rapid oral absorption, with peak plasma concentrations occurring within 1-2 hours after ingestion. The drug’s bioavailability is high, and it undergoes hepatic metabolism primarily via CYP3A4 to inactive metabolites. The elimination half-life ranges from 6 to 8 hours, supporting once- or twice-daily dosing depending on clinical response. Food does not markedly affect absorption, allowing flexibility in administration timing.

Why Tofisopam is Used for Mental Health Conditions

  • Targeted anxiolysis: By modulating sigma-1 receptors, Tofisopam reduces excessive limbic system activity without causing profound sedation, making it suitable for patients who need anxiety relief while maintaining daytime alertness.
  • Favourable side-effect profile: The lack of significant muscle relaxation and anticonvulsant activity lowers the risk of falls or respiratory depression, which is especially relevant for elderly patients or those with chronic pulmonary disease.
  • Adjunct in alcohol-withdrawal: Small trials in Europe have shown that Tofisopam can attenuate tremor and agitation during early withdrawal, offering an alternative to benzodiazepine-based protocols when sedation is undesirable.
  • Guideline positioning: In countries where it is approved, Tofisopam is listed as a second-line option for generalized anxiety disorder (GAD) after selective serotonin reuptake inhibitors (SSRIs) or buspirone, primarily when patients experience intolerable sedation from other benzodiazepines.
  • Comparison to diazepam: While diazepam provides rapid anxiolysis, its long half-life and potent sedative effect can impair cognition and increase fall risk. Tofisopam’s shorter half-life and non-GABAergic action make it a more selective anxiolytic for patients who must remain functional.

Off-Label and Investigational Uses of Tofisopam

Limited evidence from open-label studies suggests potential benefits in treating somatoform disorders and certain types of chronic tension-type headache, where central sensitisation plays a role. Small pilot trials have reported reductions in headache frequency when Tofisopam was added to standard analgesic regimens. However, these indications are not approved by the TGA, and robust randomized controlled data are lacking.

Off-label use should only be considered under the supervision of a qualified healthcare provider.

Is Tofisopam Right for You?

Patients who experience moderate anxiety but cannot tolerate the drowsiness associated with traditional benzodiazepines may find Tofisopam advantageous. It is also considered when a clinician wishes to avoid the respiratory depressant effects of GABA-A modulators, such as in individuals with chronic obstructive pulmonary disease.

Pregnancy and lactation present a cautionary scenario; animal studies have not demonstrated teratogenicity, but human data are insufficient, so the medication is generally avoided unless the therapeutic benefit clearly outweighs potential risk. Renal or hepatic impairment may prolong the drug’s half-life, prompting dose reduction to 25 mg once daily.

Patients with a history of substance use disorder should be evaluated carefully, as any anxiolytic carries a risk of psychological dependence, albeit lower for Tofisopam compared with classic benzodiazepines.

Taking Tofisopam Effectively

  • Timing: Because food does not interfere with absorption, the tablet can be taken with or without meals. Many clinicians recommend dosing in the morning to minimise any residual daytime sedation.
  • Missed dose: If a dose is forgotten and the next scheduled dose is more than six hours away, take the missed tablet immediately; otherwise, skip it and resume the regular schedule. Do not double-dose.
  • Travel considerations: For long-haul flights, a single 50 mg dose taken an hour before departure can help mitigate travel-related anxiety without causing excessive sleepiness.
  • Interaction awareness: Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase plasma levels, so dose adjustment or close monitoring is advisable. Alcohol should be limited, as it can potentiate central nervous system depression even though Tofisopam’s sedative effect is modest.

Understanding Side Effects and How to Manage Them

Common adverse events include mild dizziness, headache, and gastrointestinal discomfort. These effects are often transient and related to the drug’s central action on sigma-1 receptors, which can influence autonomic regulation.

  • Dizziness: Rising slowly from a seated position and staying hydrated can reduce orthostatic symptoms.
  • Headache: Over-the-counter acetaminophen may be used, provided it does not exceed recommended daily limits.
  • Gastro-intestinal upset: Taking the tablet with a small amount of food can alleviate nausea.

Serious reactions are rare but may manifest as severe skin rash, hepatic enzyme elevation, or signs of hypersensitivity (e.g., facial swelling). If any of these occur, discontinue the medication and seek urgent medical attention.

Buying Tofisopam from Our Online Pharmacy

Purchasing Tofisopam through a regulated online channel can simplify access for Australian residents who face limited local availability.

Why Choose Our Service?

Our online pharmacy streamlines the import-approval process, handling all required documentation with the TGA on your behalf. This reduces paperwork and shortens delivery times compared with traditional mail-order routes.

Quality & Safety

We partner with licensed international pharmacies that adhere to Good Manufacturing Practice (GMP) standards and are inspected by regulatory agencies such as the European Medicines Agency. Each batch of Tofisopam is accompanied by a certificate of analysis confirming potency and purity.

Pricing & Access

Because Tofisopam is not stocked by Australian wholesalers, our platform can source the medication at wholesale rates from European manufacturers, passing the savings directly to you. A lifetime 10 % discount applies to all repeat orders, making long-term therapy more affordable than private import services.

Discreet Delivery

Orders are packaged in unmarked, tamper-evident containers. Express shipping typically arrives within 7 days, while standard delivery may take up to 3 weeks, both with tracking options for peace of mind.

Frequently Asked Questions

  • Is Tofisopam habit-forming? While it carries a lower risk of physical dependence than classic benzodiazepines, psychological reliance can develop with prolonged use, so clinicians usually limit therapy to a few weeks.

  • Can I take Tofisopam with my SSRI? No direct pharmacokinetic interaction is known, and the combination is sometimes employed to augment anxiolysis when SSRIs alone are insufficient. Monitoring for increased serotonergic side effects is prudent.

  • How does Tofisopam differ from buspirone? Buspirone acts as a partial agonist at 5-HT1A receptors, whereas Tofisopam modulates sigma-1 receptors. The latter provides a faster onset of anxiolysis but may cause mild dizziness, while buspirone requires several weeks to reach full effect.

  • Will Tofisopam affect my driving ability? Most patients report minimal sedation, yet individual responses vary. It is advisable to assess personal tolerance before operating vehicles, especially after the first dose.

  • Is Tofisopam safe for elderly patients? Its limited sedative profile makes it a reasonable option for older adults, but dose reduction to 25 mg daily is often recommended to mitigate the risk of falls.

  • Can Tofisopam be used for insomnia? Because it does not possess strong hypnotic properties, it is not indicated for primary sleep disorders. Patients seeking sleep aid should discuss alternative treatments with their clinician.

  • What should I do if I miss a dose while traveling across time zones? Adjust the dosing schedule gradually to align with the new local time, maintaining a minimum 6-hour interval between doses to avoid accumulation.

  • Is there a generic version of Tofisopam available in Australia? The medication is itself a generic compound; however, it is not listed on the Australian Register of Therapeutic Goods, so any supply must be imported under a personal import permit.

  • How does Tofisopam interact with alcohol? Although its sedative effect is modest, concurrent alcohol can enhance central nervous system depression, potentially leading to excessive drowsiness or impaired coordination. Limiting alcohol intake is advisable.

  • Will Tofisopam cause weight gain? No clinically significant weight changes have been reported in the limited studies available.

  • Is Tofisopam covered by Australian health insurance? As an unapproved therapeutic good, it is not eligible for reimbursement under the Pharmaceutical Benefits Scheme (PBS).

Glossary

Sigma-1 receptor
A protein located in the endoplasmic reticulum that modulates calcium signaling and neuroplasticity, implicated in anxiety and neuroprotection.
CYP3A4
A liver enzyme responsible for the metabolism of many drugs; inhibitors can increase plasma concentrations of substrates like Tofisopam.
Bioavailability
The proportion of an administered dose that reaches systemic circulation in an active form.

Disclaimer

The information provided about Tofisopam is for general knowledge only and does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. Readers are assumed to be responsible adults capable of making informed health decisions. Our online pharmacy offers access to Tofisopam for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.

External Resources about Tofisopam


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD